跳至主要内容
临床试验/NCT00668681
NCT00668681撤回不适用

Safety Data Collection for Delivery System and Use of Staple in Endovascular Procedures

Lombard Medical13 个研究点 分布在 1 个国家开始时间: 2008年4月1日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
试验地点
13

研究概览

简要总结

This study is intended to provide data to verify safe delivery of a staple previously intended for use in open surgical procedures. A newly modified delivery system will provide endovascular access for implantation of a staple during endovascular graft procedures.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female >21 years of age
  • Undergoing endovascular stent grafting for AAA repair
  • Post endovascular stent grafting where stent stabilization is necessary due to stent fixation failure and/or persistent endoleak.

排除标准

  • Religious, cultural or other objection to the receipt of blood, or blood products.
  • Unwilling to comply with follow-up schedule
  • Unwillingness, or inability to provide informed consent to both trila and procedure
  • Ruptured Aneurysm
  • Area where staple is to be placed has significant loose thrombus associated with it
  • Acute or chronic aortic dissection or mycotoc aneurysm
  • Allergy to device materials
  • Allergy to or intolerance to use of contrast media or cannot be exposed to suitable remedial treatment such as steroids and/or diphenhydramine.
  • Clinically and morbidly obese such that imaging would be severely adversely affected.
  • Uncorrectable bleeding abnormality
  • Inflammatory aneurysm
  • Connective tissue disease (e.g., Marfans syndrome, Ehlers Danlos syndrome)
  • Patients with PTFE grafts
  • Patients with investigational grafts (i.e., those grafts that are not FDA approved)

研究者

发起方
Lombard Medical
申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验